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Objectives: Radical perineal prostatectomy (RPP) is an alternative to the retropubic, laparoscopic or
robotic prostatectomy approaches. This study reports the experience with RPP of a single surgeon at
a single institution; the technical aspects, oncological outcome, and complications, such as urinary
incontinence and erectile dysfunction, were investigated.
Methods: A total of 212 consecutive patients with a mean age of 63 (range 45e74) years and clinically
localised prostate cancer were monitored. Between January 2001 and December 2010, all patients
underwent RPP that was performed by a single experienced surgeon at one institution. All data were
introduced into a database focussing on the intra-operative and post-operative complications, conti-
nence rate, potency and oncological outcome.
Results: The mean follow-up was 48 (6e117) months. Intra-operative complications, both early and late,
occurred in 19% of the patients. The average length of in-hospital stay was 9 (3e45) days, and the mean
period of time spent with a urethral catheter in place was 9 (4e45) days. The continence rate was 81%,
and the potency rate, without any pharmacological aid, was 27%. The overall PSA-free survival rate was
86%. There was one cancer-speciﬁc death.
Conclusion: On the basis of our prospective data, we conclude that RPP provides satisfactory oncological
results with an acceptable outcome in terms of quality of life. RPP can be considered to be mini-invasive
and achieves results that are equivalent to those of the alternative surgical approaches.
 2011 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Radical prostatectomy is considered as the most reliable
approach to the eradication of localised prostate cancer (PC).1 There
are four approaches to perform this surgery: the retropubic tech-
nique and the perineal technique for open surgery, the laparoscopic
technique, which is so-called “minimally-invasive-method” and
the robotic prostatectomy.
As early as 1867, Billroth ﬁrst used the perineal approach2 to the
prostate, but this access did not become popular. In spite of this,
Young3 used a perineal approach in 1904 and, currently, this
approach, with the modiﬁcations of Dees4 and Vest,5 is the most
frequently used in radical perineal prostatectomy (RPP). Before the
1970s, many urologists utilised RPP, which was indicated for patients
withwell-differentiated, small, localised cancers.6 On the basis of the
anatomical studies by Walsh and Donker,7 the retropubic approach
was more widely accepted and largely replaced the perineal
approach. In 1985, Weiss8 performed the ﬁrst nerve-sparing RPP.: þ39 0471 909738.
loj).
ciates Ltd. Published by Elsevier LtHis technique is the basis of all nerve-sparing approaches that have
been used to date. In the 1990s, the laparoscopic radical prostatec-
tomy (LRP) technique was developed as a minimally-invasive9 alter-
native to the retropubic radical prostatectomy (RRP) and RPP
approaches. The experience with the LRP by Schuessler9 was so bad,
that surgeons avoided this operation until Guillonneau et al.10e12 led
to widespread adoption of this technique.
We began using this technique in 2001with slight modiﬁcations
to the standard procedure. Here, we present our experience with
this technique.2. Material and methods
2.1. Selection criteria
RPP is only considered in patients with a PSA level<10 ng/ml, a prostate volume
<50 ml in the absence of a prominent middle lobe and a Gleason score 7(3 þ 4). A
Gleason score of 4 þ 3 is a relative indication at this institution for bilateral staging
lymphadenectomy, and therefore RRPs are performed in those cases.
The bilateral nerve-sparing technique is performed only in tumours with
a Gleason score of 6 and two or less positive biopsies out of ﬁve per site, at this time.
This technique is considered only in patients with good erectile function.d. All rights reserved.
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The technique follows mainly as described by Paulson13 and differs solely in the
preparation of neurovascular bundle. In short, the two layers of the fascia were
injected with saline solution centrally over the prostate gland to provoke a hydro-
distention of the two parts and then coloured with methylene blue. After 1 min,
excess methylene blue was washed off with saline solution and the neurovascular
bundles remained a deep blue colour. With careful sharp dissection, the cavernosal
nerve bundles and the attached fascia were separated from the prostate from the
apex to the base. This procedure was performed bilaterally.
After removal of the prostate the reconstruction of the bladder neck was per-
formed using the “tennis-racquet-technique”. The ﬁrst three stitches of the anas-
tomosis on the anterior face were placed followed by a running suture for the
remaining circumference. Once the anastomosis was completed, an 18Fr catheter
was placed transurethrally under digital protection of the anastomosis. The bladder
was then ﬁlled with 300 ml of saline solution to check the watertightness.
After control of the anterior rectal wall, a Jackson-Pratt-drain was placed, the
centrum tendineum was reconstructed with single stitches and the skin was with
metallic clips.
Ambulation and normal diet were advanced the morning after surgery; the
drain was removed when drainage decreased to less than 50 ml in 24 h. If on post-
operative day 5 a cystogram didn’t show any leakage, the catheter was removed. The
postvoid residual volumewas determined three times and was required to be below
50 ml. On post-operative day 8, the metallic clips were removed and a continence
reduction-programwas initiated. After three weeks, all activities were unrestricted.
The ﬁrst follow-up visit with measurement of the PSA value occurred 3 months
after the operation and was repeated every 3 months for the ﬁrst 2 years, every 6
months up to year 5 and then annually for life. PSA values <0.03 ng/ml were
considered undetectable, and PSA values above 0.2 ng/ml were considered
a biochemical relapse.
All data were recorded in a database by the surgeon after surgery and during
follow-up visits. The continence evaluations were carried out and recorded by the
stoma nurses and the data were inputted into the database.3. Results
3.1. Patient characteristics
A total of 212 consecutive procedures that were performed by
a single experienced surgeon were prospectively accumulated
between January 2001 and December 2010 (Table 1). The mean
patient age was 63 (45e74) years. The mean prebiopsy PSA level
was 6.07 (1.2e15.07) ng/ml. Themean biopsy Gleason score was 5.7
(3e9), and the mean operative specimen Gleason score was 6.0
(4e9). The average prostate weight was 42 (6.3e148) g. The mean
hospital stay was 9 (3e45) days.
In patients with a Gleason score >7 in the operative prostate
specimen, the biopsy Gleason score was recalculated and showed
an underestimation of the ﬁrst biopsy Gleason score. Therefore,
there were patients with Gleason scores>7 at the deﬁnitive biopsy.
The mean catheter indwelling time was 9 (4e45) days, and
75.5% of the patients who were able to void with a post-residual
volume that was less than 50 ml were discharged withoutTable 1
Patient characteristics.
Variable n ¼ 212
Mean age (range) 63 (45e74) years
Mean preoperative PSA (range) 6.07 (1.2e15.07) ng/ml
Preoperative gleason score (range) 5.7 (3e9)
Mean prostate weight (range) 42 (6.3e148) g
pT2a 47 (22.2%)
pT2b 20 (9.4%)
pT2c 99 (46.7%)
pT3a 27 (12.7%)
pT3b 11 (5.2%)
pT4 8 (3.8%)
Mean operative duration (range) 84 (57e235) min
Mean hospital stay (range) 9 (3e45) days
Positive margins 47 (22.2%)
Mean follow-up 48 (6e117)a catheter: 5 (2.3%) patients underwent catheter replacement for
urinary retention, and 4 (1.9%) patients were discharged with
a catheter due to leakage of the anastomosis.
3.2. Cancer characteristics
We found that 78.3% (166/212) of the patients had organ-
conﬁned tumours (pT2aec), 18% (38/212) had extracapsular disease
and 3.7% (8/212) had pT4 tumours. Detailed patient characteristics
are provided in Table 2. An overall rate of clean margins of 78%
(165/212) was obtained; 23/47 (49%) positive margins were
observed in organ-conﬁned tumours, whereas the remaining 51%
(24/47) of positive margins were observed in cases that involved
local advanced tumour stages.
The overall surgical positive margin rate in organ-conﬁned
tumours (T2) was 13.8% and the overall positive margin rate in non
organ-conﬁned tumours (T3eT4) was 52%.
In addition, 29/47 (62%) patients with positive margins did not
develop a biochemical recurrence after a mean follow-up time of 48
(6e117) months. A positive margin is deﬁned as the present of
tumour cells at the ink marked surface of the specimen. It impli-
cates that a laceration of the surgical capsule can cause a false
positive surgical margin. It explains why there is a gap between the
number of positive margins and the biochemical recurrence rate.
A lack of biochemical recurrence was observed in 86% (182/212)
of patients, whereas evidence for biochemical recurrence was
observed in 14% (30/212) of patients. To date, 13.6% (29/212), 5.2%
(11/212) and 0.4% (1/212) of patients have been treated with radi-
ation therapy, hormone therapy and chemotherapy, respectively.
There has been one PC related death; all other cases (n ¼ 8) were
not cancer related.
3.3. Urinary continence
After a mean follow-up time of 48 (6e117) months, 173/212
(81%) patients were completely continent (no loss of any urine);
30/212 (14%) patients were not wearing any protection but some-
times reported some leakage of drops especially when they were
particularly physically exhausted, and therefore, could not be
classiﬁed as continent. Only 8 patients (3.7%) were suffering from
grade II stress urinary incontinence (SUI). One patient (0.4%)
complained of grade III SUI and was successfully treated with an
artiﬁcial sphincter (AMS 800). One patient (0.4%) underwent
a cystectomy due to invasive bladder cancer.
3.4. Erectile function
Criteria for the consideration of cavernosal nerve preservation
were based upon the staging of 10 biopsies cores. Nerve preser-
vationwas only considered at this time in fully potent patients with
no more than 2/5 positive cores per side. Therefore, only 103/212
patients (48.6%) underwent a nerve-sparing procedure. In 77 cases,
a bilateral preservationwas performed, and in 26 cases, a unilateralTable 2
Pathological stages and corresponding percentage positive margin rates n ¼ 212.
Stagea Total Positive margin in % (n)
pT2a 47 6.4 (3)
pT2b 20 5 (1)
pT2c 99 19.2 (19)
pT3a 27 40.7 (11)
pT3b 11 54.5 (6)
pT4 8 87.5 (7)
a Pathologic stages based on the 2003 TNM classiﬁcation.
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excluded due to lack of sufﬁcient follow-up data, leaving 89
patients for the analysis. In 62/89 patients (70%), a recovery of
spontaneous erections occurred within 6 months, but only 14 (16%)
of them stated that the erection was of the same quality (E4-5) as
before the RPP. A total of 24/89 (27%) patients were able to perform
satisfactory penetration without use of any pharmacological aid,
and 11/89 patients (12%) had spontaneous erections but required
phosphodiesterase type 5 (PDE5) inhibitors to perform intercourse.
3.5. Complications
A total of 170/212 (80.1%) of the patients experienced no
complications of any kind, and 42 patients had various complica-
tions (Table 3).
In 11 cases (5.2%), rectal perforations or lacerations occurred,
which were immediately repaired using a double layer technique.
The post-operative care was carried out as usual. In 10 cases, no
healing delay or other problemswere observed. In one case, a stool-
ﬁstula was observed 21 days after the operation, which was treated
with parenteral alimentation for 10 days; fortunately, the ﬁstula
healed spontaneously.
Three patients (1.4%) developed a urethro-cutaneous ﬁstula,
which was resolved within 38 days with a new placement of
a transurethral catheter. In one case, a concomitant perineal hae-
matoma was treated with evacuation of the haematoma and
secondary suturing of the anastomosis. In this case, the catheter
remained in place for 45 days.
In three (1.4%) cases, a haematoma was observed; one was
treated surgically as reported above, and the other two were fol-
lowed conservatively.
Three (1.4%) patients required haemotransfusions with a total of
6 units of blood.
Two patients experienced a transient hypoparesthetic lesion of
the left lower limb as a consequence of incorrect patient-
positioning.
In ﬁve cases (2.3%), delayed perineal wound healing was
observed. In one case, a preserved neurovascular bundle was
accidentally injured by a valve.
4. Discussion
The goal of modern radical prostatectomy is to excise all cancer
with the least morbidity and to increase the chances of a full
recovery of continence and potency. LRP has now become very
popular and has supposedly surpassed the other approaches in
terms of convalescence and short term morbidity.14 RPP is one of
four approaches that are currently used to treat surgically localised
PC. Gibbons and Iselin have demonstrated excellent cancer control
inpatientswhowere followed for 20years after RPPandhave shownTable 3
Intra-operative, post-operative and late complications.
Complications n (%) Late complications (%)
Rectum injury 11 (5.2) e
Uretherocutaneous ﬁstula 3 (1.4) e
Hypoparesthetic lesion 2 (0.9) e
Ureter injury 1 (0.5) e
Blood transfusion 3 (1.4) e
Perineal haematoma 3 (1.4) e
Stool-ﬁstula 1 (0.5) e
Urinary retention 24 (11%) e
Wound dehiscence 6 (4.6%) e
Anastomosis stricture e 3 (1.4)
Death 1 (0.4%)that locally conﬁned cancers can be safely removed with good long
term tumour-free survival using the perineal approach.15,16
While body habitus and prior abdomino-pelvic surgery have
a negative impact on a given patient’s candidacy for LRP, and to
some extent RRP, all patients who are candidates for prostatectomy
can undergo RPP. We observed an incidence of lower extremity
neuropraxia after the perineal approach of 0.9%, which is signiﬁ-
cantly lower than the 21% reported by Price et al.17
The perineal access has the advantage of an easy dissection and
anastomosis of the urethra, and prior operations in the pelvis have
no negative impact on the surgical procedure as well as a supra-
pubic femoro-femoral bypass.18 A very high body mass index does
not increase the difﬁculty of the operation, in contrast to the two
other techniques. It is a technique that is highly economical and
cost effective and could be used in many countries where robotic or
even laparoscopic surgery is not available or the surgeons are not
adequately trained in RRP. It generally involves less use of resources
and less immediate morbidity.
Bishoff19 reported a higher rate of faecal soilage following
perineal versus RRP; however, their perineal incision extended 2 cm
posterior to the anal oriﬁce. In our series, neither stool incontinence
nor faecal urgency or ﬂatus during valsalva manoeuvres was
observed, in contrast to the series by Harris.18 Therefore, this is
probably the reason that this approach, according to Young, avoids
any sphincteric structures of the rectum.
The perineal route permits excellent exposure of the apex and
facilitates an exact anastomosis of the urethra. Nevertheless it
appears that none of the techniques is superior to the others.14 In
our series, 81% of the patients were completely dry (no drop) and
additionally, 14% were not using protective pads but reported
occasional leakage under special conditions. Unfortunately, the
continence evaluation was not standardised, and therefore, the
comparisonwith other series is rather problematic (dry, totally dry,
social dry, pad free, etc). In a review article by Rassweiler et al.,14 the
range of continence rate after LRP, RRP, and RPP was between 50
and 91.7% with all the difﬁculties mentioned above.
Our series had a 22.2% positivemargin, whichwas deﬁned as the
presence of cancer at the inked margin of resection on the surgical
specimen.20 This was slightly lower than the 23% reported by
Paulson et al.13 but twice as high as that reported by Sullivan et al.6
for the RPP. Sullivan reported an equal value for the retropubic
approach in the same series. In an actual overview,14 a positive
margin rate for LRP from 16%21 up to 30%22 has been reported. No
signiﬁcant advantage of one technique could be identiﬁed.
Of the 47 (22.2%) patients who had a positive margin, only 18
(38.3%) experienced a biochemical failure after a mean follow-up
time of 48 (6e117) months. We noted an overall biochemical
progression-free survival of 86%. These data are comparable to
those of the series by Guillonneau12 and the series by Salomon,
which compared all three therapeutic options.23
Due to the relative rigid criteria for nerve-sparing, only 48.6% of
the patients in this series underwent nerve-sparing procedures. Of
the 103 patients, 13% were excluded due to lack of sufﬁcient follow-
up data, leaving 89 patients for analysis. Overall, 68% of the patients
experienced recovery of spontaneous erection, but only 70% were
able to perform satisfactory penetration without the use of phos-
phodiesterase type 5 (PDE5) inhibitors. A point of concern in nerve-
sparing RPP is the need to move the rectum backwards. During this
manoeuvre the neurovascular bundles can be lacerated even if they
are running laterally. Afterwards they have to be dissected from the
prostate when the prostate is removed. This results in signiﬁcantly
more trauma to the neurovascular bundles reported in this series
and decreases the chances of recovering erectile function. Hence
the relatively poor recovery of sexual function in the patients
reported in this series. Nevertheless, this series can be compared to
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However, all of these comparisons are limited by variations in the
study population size, patient characteristics and multiple other
factors that are known to affect potency.
One of the greatest advantages of RPP is the low blood trans-
fusion rate. Admittedly, an exact measurement of blood loss in our
series was not feasible because when the bladder neck was opened
urine was included in the liquid removed by the suction apparatus
and therefore reﬂected a combination of blood and urine. Indi-
rectly, in the ﬁnal analysis, the blood transfusion rate of 1.4% was
low, and was lower than that of all the LRP series reported by
Touijer24 and Lein.25
5. Conclusions
Single surgeon non comparative experience demonstrate that
RPP provides fair results in terms of pain, complications, trans-
fusion rate, continence, positive margins and cosmetics. RPP meets
every goal of minimally-invasive-surgery26 with few economical
burdens.
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